SCHEMBL7804662

SCHEMBL7804662

CN(C)CCn1nc2c3c(c(Cl)ccc31)C(=O)c1cnccc1-2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 12/20 0.48
TDP2 O95551 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
CDC25B P30305 1/20 0.35
EGFR P00533 2/20 0.34
PRKCG P05129 1/20 0.33
PRKCB P05771 1/20 0.33
PRKCA P17252 1/20 0.33
GSK3B P49841 1/20 0.33
PRKCZ Q05513 1/20 0.33
PRKCD Q05655 1/20 0.33
KCNH2 Q12809 1/20 0.33
KDM4E B2RXH2 1/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
CASP1 P29466 1/20 0.33
BLM P54132 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CHEK1 O14757 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7812061 0.94 TOP2A (0.45) TOP2ATDP2TDP1PRKCGPRKCB
SCHEMBL7814010 0.90 TOP2A (0.45) TOP2ACDC25BSMN1; SMN2
SCHEMBL8848089 0.86 TOP2A (0.46) TOP2ATDP1CDC25BKDM4ETP53
SCHEMBL8847912 0.86 TOP2A (0.46) TOP2ACDC25BKDM4ETP53CYP3A4
SCHEMBL7817561 0.85 TOP2A (0.41) TOP2ACDC25BKDM4ETP53CYP3A4
SCHEMBL8847987 0.84 TOP2A (0.45) TOP2ATDP1CDC25B
SCHEMBL7804758 0.84 TOP2A (0.43) TOP2ATDP2TDP1
SCHEMBL7812072 0.82 MAPK13 (0.44) TOP2ACDC25BEGFRKDM4ETP53
SCHEMBL7810337 0.81 TOP2A (0.43) TOP2ATDP2TDP1TP53CYP3A4
SCHEMBL7804809 0.81 ECE1 (0.47) TOP2ATDP2TDP1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0750619-B1 HETERO-ANNULATED INDAZOLES NOVUSPHARMA SPA (IT) 2001-05-30 EP disclosed
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 EP disclosed
US-5604246-A HAVING POTENCY AGAINST MULTIDRUG RESISTANT TUMORS BOEHRINGER MANNHEIM ITALIA SPA (IT) 1997-02-18 US disclosed
US-5596097-A ANTITUMOR AGENTS THE UNIVERSITY OF VERMONT (US) 1997-01-21 US disclosed
EP-0750619-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1997-01-02 EP disclosed
US-5519029-A ANTITUMOR AGENTS BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1996-05-21 US disclosed
WO-1995024407-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1995-09-14 WO disclosed
EP-0662076-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1995-07-12 EP disclosed
WO-1994006795-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1994-03-31 WO disclosed